HIRECT (HIRECT) Fair Value & Analysis

Industrials · Market cap ₹39.2B

H HIRECT HIRECT · NSE

Price₹1,141

Fair Value₹248.26

Upside-78.2%

Quality52/100

Watch HIRECT for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range ₹168.76 – ₹334.49

Fair value as of: Jul 3, 2026

From 16 valuation models · updated today

Share price +2.9% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹579.80 – ₹1,000,000 · fair‑value band ₹168.76 – ₹334.49 · the ₹1,141 price screens above the ₹248.26 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HIRECT (HIRECT) currently trades at ₹1,141, while our model-based Fair Value estimate is ₹248.26 — implying the stock looks roughly 78.2% overvalued today. We read business quality at 52/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, HIRECT generated revenue of ₹10.0B at a net margin of 4.5%. Revenue grew 51.2% year over year. It earns a return on equity of 21.1%. Net debt stands at ₹2.4B. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹10.0B

Revenue growth (YoY) +51.2%

Net margin 4.5%

Return on equity 21.1%

Free cash flow −₹262M FY2026

P/E ratio 83.2

More key figures

Operating margin 1.6%

EPS (TTM) ₹13.72

Dividend yield 0.1%

EPS growth (YoY) -54.9%

Net debt ₹2.4B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HIRECT reported revenue of ₹10.0B in FY2026 versus ₹3.7B in FY2022, a compound +28.0%/yr. Reported net income was ₹450M in FY2026, compounding +55.0%/yr from FY2022.

Revenue +28.0%/yr

FY22 ₹3.7B

FY23 ₹3.6B

FY24 ₹5.2B

FY25 ₹6.6B

FY26 ₹10.0B

Net income +55.0%/yr

FY22 ₹78.0M

FY23 −₹63.6M

FY24 ₹125M

FY25 ₹371M

FY26 ₹450M

Is HIRECT fairly valued? → Check now

Similar stocks

6 more Electrical Equipment & Parts stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
Contemporary Amperex Technology Co CYATY	$23.70	$14.62	-38%
3750 3750	HK$681.00	HK$378.25	-44%
ABB Ltd ABLZF	$110.87	$35.93	-68%
DELTA DELTA	335.00 THB	34.23 THB	-90%
Vertiv Holdings VRT	$357.96	$89.54	-75%
Mitsubishi Electric Corporation MIELY	$68.31	$29.03	-58%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is HIRECT (HIRECT) undervalued?

As of Jul 3, 2026, our model estimates a fair value of ₹248.26 versus a price of ₹1,141 — about −78% (overvalued). Model-based estimate, not financial advice.

What is the fair value of HIRECT?

Our model-based fair value for HIRECT is ₹248.26 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹1,141.

What is the quality score of HIRECT?

HIRECT has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of HIRECT (HIRECT)?

HIRECT reported trailing-twelve-month revenue of about ₹10.0B (latest available figure, as of Jul 3, 2026).

What is the net profit margin of HIRECT?

The net profit margin of HIRECT is about 4.5%, meaning it keeps roughly 4.5% of revenue as net income. Based on the latest reported figures.

Does HIRECT pay a dividend?

HIRECT currently shows a dividend yield of about 0.12% relative to its recent price (as of Jul 3, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.